Hudson Edge Investment Partners Inc. Buys 52,043 Shares of AdaptHealth Corp. $AHCO

Hudson Edge Investment Partners Inc. grew its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 84.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 113,679 shares of the company’s stock after purchasing an additional 52,043 shares during the period. Hudson Edge Investment Partners Inc. owned about 0.08% of AdaptHealth worth $1,353,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in AdaptHealth by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 60,495 shares of the company’s stock valued at $656,000 after purchasing an additional 2,564 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in AdaptHealth by 32.4% in the first quarter. Goldman Sachs Group Inc. now owns 571,232 shares of the company’s stock valued at $6,192,000 after buying an additional 139,828 shares in the last quarter. Woodline Partners LP bought a new stake in shares of AdaptHealth during the first quarter worth $2,851,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of AdaptHealth by 18.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 233,780 shares of the company’s stock worth $2,534,000 after buying an additional 35,879 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of AdaptHealth by 1.3% during the second quarter. JPMorgan Chase & Co. now owns 211,769 shares of the company’s stock worth $1,997,000 after buying an additional 2,718 shares in the last quarter. 82.67% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, insider Russell E. Schuster III sold 11,275 shares of AdaptHealth stock in a transaction on Monday, June 1st. The shares were sold at an average price of $10.06, for a total value of $113,426.50. Following the completion of the sale, the insider owned 136,538 shares in the company, valued at $1,373,572.28. The trade was a 7.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on AHCO. Truist Financial increased their price target on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Monday, April 13th. UBS Group reduced their price objective on AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a research report on Wednesday, May 6th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of AdaptHealth in a report on Friday, May 22nd. Jefferies Financial Group reiterated a “hold” rating and issued a $11.00 target price on shares of AdaptHealth in a research report on Monday, April 20th. Finally, Canaccord Genuity Group lifted their price target on AdaptHealth from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Five equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $14.29.

AdaptHealth Stock Performance

Shares of AHCO stock opened at $10.76 on Friday. The business’s 50 day simple moving average is $10.66 and its 200 day simple moving average is $10.61. AdaptHealth Corp. has a one year low of $8.51 and a one year high of $13.43. The stock has a market capitalization of $1.46 billion, a PE ratio of -17.35, a PEG ratio of 0.55 and a beta of 1.45. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.92 and a quick ratio of 0.71.

AdaptHealth Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.